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Objective: The potential beneficial effects of red wine consumption on the development of atherosclerotic disease have
been previously suggested in the literature. Vascular smooth muscle cell (SMC) proliferation is an important component
of atherogenesis. Inhibition of vascular SMC proliferation may have a beneficial effect in retarding the development of
atherosclerotic disease. The goal of this study was to determine the effect of red wine, red wine polyphenol extract, and
resveratrol, a polyphenol commonly found in red wine, on the proliferation of vascular SMC in culture.
Methods: Bovine aortic SMCs were used for all experiments. SMCs were treated with growth media supplemented with
dealcoholized red wine, red wine polyphenol extract, or resveratrol at various concentrations for as long as 48 hours. SMC
proliferation was assessed with 3H-thymidine DNA incorporation assay. SMC viability was assessed with trypan blue
exclusion studies and a colorimetric lactic dehydrogenase cytotoxicity assay.
Results: Our results show that red wine and red wine polyphenol extract inhibit SMC proliferation in a dose-dependent
fashion. Resveratrol also inhibits vascular SMC proliferation. SMC viability studies show that this inhibition of SMC
proliferation is not the result of a cytotoxic effect.
Conclusion: Our findings show that red wine and red wine polyphenols have an inhibitory effect on the proliferation of
vascular SMCs in culture. These results suggest that the observed beneficial effects of red wine may be the result, in part,
of the inhibition of vascular SMC proliferation. Furthermore, the antiproliferative properties of red wine may be caused
by its component polyphenols. (J Vasc Surg 2002;35:1226-32.)
The beneficial effects of red wine consumption on the
development of atherosclerotic disease have been sug-
gested for several years. The predominant basis for this
belief is epidemiologic and has been commonly referred to
as “the French Paradox.” Simply stated, the typical French
diet is two to three times higher in saturated fats than the
usual American diet, yet the rates of cardiovascular disease
in France are one third those of the United States. One
hypothesis for the difference in cardiovascular disease prev-
alence between the two countries is based on differences in
per capita red wine consumption.1 The typical Frenchman
drinks three times as much red wine as his American coun-
terpart. The hypothesis proposes that the decreased preva-
lence of cardiovascular disease in France is the result of the
beneficial effects of substances contained in red wine. Not
surprisingly, this has created an impetus for researchers to
study red wine and determine what effect, if any, it has on
the development of atherosclerosis.
Atherosclerosis is a multifactorial disease process, char-
acterized by plaque formation and progressive narrowing of
the lumen diameter. The proliferation of vascular smooth
muscle cells (SMCs) in the arterial intima is a key step in the
formation of atherosclerotic plaques.2,3 The purpose of this
study was to elucidate some of the potential antiatheroscle-
rotic effects of red wine. Our goal was to compare the
biologic effects of red wine and resveratrol on cellular
processes. Specifically, we sought to determine whether red
wine, red wine polyphenol extract, or resveratrol inhibited
the proliferation of vascular SMCs.
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MATERIALS AND METHODS
Materials
Tissue culture plasticware was obtained from Becton
Dickinson (Franklin Lakes, NJ). Growth media (Dulbec-
co’s modified Eagle’s medium/F12) were purchased from
Gibco (Carlsbad, Calif), resveratrol was obtained from
Sigma (99% purity; R5010, St Louis, Mo), and tritiated
(methyl 3H) thymidine (2 Ci/mmol) was obtained from
Amersham (Piscataway, NJ). Primary cultures of SMCs
were derived from newborn calf thoracic aorta, as described
previously.4 Briefly, adventitia and intima were removed
from the newly harvested aorta, and finely cut strips of
media were placed in a tissue culture flask to allow for
attachment. After 4 hours, growth media (Dulbecco’s
modified Eagle’s medium/F12) containing 20% newborn
calf serum from Gemini (Calabasas, Calif) were added and
were changed every 3 days. After several days in culture,
SMC outgrowths from the primary tissue explants became
apparent. On reaching confluence, the tissue explants were
discarded, and the SMCs were passaged. Passage of SMCs
was accomplished with trypsinization of primary cultures
and dispersion into tissue culture flasks every 6 to 9 days,
followed by the addition of 10% media. All experiments
were conducted on cells between passages 2 and 6.
Preparation of dealcoholized red wine. A 2000 Cal-
ifornia Petite Sirah (Bogle Winery, Clarksburg, Calif) was
chosen because of its high polyphenol content (2.5
g/L).5,6 A 20-mL sample of wine was used to prepare the
stock solutions. Ethanol was removed from the sample with
rotary evaporation to 75% of the original volume with
reduced pressure at 35° C. A final volume of 20 mL was
achieved with the addition of ultrapure water. A 3-mL
aliquot of dealcoholized wine was set aside for polyphenol
extraction.
Preparation of red wine polyphenol extract. A
3-mL aliquot of dealcoholized red wine was passed
through a C18-SPE cartridge (1 g Supelco, Sigma) placed
in a vacuum elution apparatus that had been precondi-
tioned with a 1:1 methanol-acetone mix and rinsed with
water. The eluant was collected in a glass vial, 6 mL of water
was passed through after the sample, and the eluant was
rotary evaporated to a final volume of 3 mL. This water
fraction contained polar organic acids, alcohols, and resid-
ual sugars.
To elute the phenolic compounds from the C18 col-
umn, an admixture of approximately 8 mL of 1:1 methanol-
acetone was passed through the column. After half the
solvent had passed through the C18 material, 100 L of
2.8 N HCl was added to the remaining solvent toward the
end of the flush. The eluant was rotary evaporated to a final
volume of less than 2 mL and diluted with a minimal
amount of water to the final volume of 2 mL.5,6
Methods
3H-thymidine incorporation assay. SMCs were plated
into 24-well culture plates and were induced to grow with the
addition of 10% media. After 24 hours, the media were
changed (control) or replaced with 10% media supplemented
with different concentrations of dealcoholized red wine,
polyphenol extract, or resveratrol. After 6 hours, 2 Ci of
3H-thymidine was added to each well. The reaction was
terminated at 12 hours with washing with phosphate-buffered
saline solution and then incubating in 10% trichloroacetic acid
for 30 minutes at 4° C. SMCs then were washed with 95%
ethanol. Four hundredL of 0.2 N NaOH was added to each
sample and incubated for 1 hour at room temperature. Three
hundred L from each sample then was transferred to a
scintillation vial. Rate of DNA synthesis was determined with
measurement of 3H-thymidine incorporation with a scintilla-
tion counter. Experiments were repeated at least in triplicate.
Morphologic analysis. SMCs were plated into 6-well
plates and induced to grow with the addition of 10% media.
After 24 hours, the media were changed (control) or re-
placed with 10% media supplemented with dealcoholized
red wine, polyphenol extract, or resveratrol. At 48 hours,
SMCs were photographed with low-power magnification
(4) with gross examination of cell morphology and pro-
liferation. To confirm cell viability, SMCs were exposed to
dealcoholized red wine, polyphenol extract, and resveratrol
for 12 hours and then stained with 0.1% trypan blue. Cells
were photographed with high-power magnification
(400). Viable cells with an intact membrane excluded
trypan blue and were not stained.
Cytotoxicity assay. SMCs were plated in 6-well plates
and induced to grow with the addition of 10% media. After
24 hours, the media were changed (control) or replaced
with 10% media supplemented with dealcoholized red
wine, polyphenol extract, or resveratrol. At 12 hours, 50
L of media was removed from each sample population and
plated in a 96-well plate. A nonradioactive colorimetric
cytotoxicity assay that measures serum lactic dehydroge-
nase released from damaged cells was used to assess the
cytotoxicity of the different substances (Promega, Madi-
son, Wis). A 96-well plate reader was used to record the
absorbance at 490 nm, which is related to the amount of
LDH in the serum of the treated samples.
Statistical analysis. The results are presented as the
mean  SEM. Two-tailed analysis of variance was used to
analyze the difference between control and treated groups.
A P value of less than .05 was considered to be statistically
significant.
RESULTS
3H-thymidine incorporation assay. Our results show
that red wine, red wine polyphenol extract, and resveratrol
inhibit SMC DNA synthesis, as measured with 3H-thymidine
incorporation assay, in a dose-dependent manner. For
SMCs treated with red wine, our studies showed significant
inhibition of 3H-thymidine incorporation into cellular
DNA. Red wine, at concentrations of 0.1% and 1%, caused
a 42.5% and 64.6% decrease in 3H-thymidine incorpora-
tion, respectively (P  .05, N  3; Fig 1). Polyphenol
extract, at concentrations of 0.1% and 1%, resulted in a
57.6% and 71.4% decrease in 3H-thymidine incorporation,
respectively (P  .05, N  3; Fig 2). Resveratrol, at
JOURNAL OF VASCULAR SURGERY
Volume 35, Number 6 Araim et al 1227
concentrations of 10 m and 100 m, caused a 43.9% and
96.2% decrease in 3H-thymidine incorporation, respec-
tively (P  .05, N  3; Fig 3).
Morphologic analysis. No gross morphologic
changes were observed in SMCs exposed to red wine,
polyphenol extract, or resveratrol for as long as 48 hours.
However, a dose-dependent decrease was seen in the total
number of SMCs in samples treated with all three sub-
stances (Fig 4). Trypan blue staining confirmed that SMCs
exposed to red wine, polyphenol extract, and resveratrol
excluded the trypan blue staining similar to control sam-
ples, showing their viability (Fig 5).
Cytotoxicity analysis. Analysis of serum LDH levels
in treated SMC samples with a colorimetric assay showed
no significant increase in the culture media of SMCs ex-
posed to red wine, red wine polyphenol extract, or resvera-
trol, as compared with control samples. This is consistent
with the concept that the observed antiproliferative effect
of these substances is not likely the result of a cytotoxic
effect.
DISCUSSION
Wine contains many polyphenolic antioxidant sub-
stances. The origin of most of these substances is the grape
berry. Polyphenolic compounds are found in many foods of
plant origin, such as fruit, tea, coffee, and chocolate. The
level of polyphenols in a particular bottle of wine depends
on two major factors. The most important consideration is
that red wine is made by fermenting the grape juice in the
presence of grape solids (seeds and skin) and white wine is
made by pressing the juice away from the grape solids and
then allowing it to ferment. The grape skin and seeds
contain most of the polyphenols, and the grape flesh con-
tains a relatively small percentage of the total polyphenols.
A typical bottle of red wine contains 1.8 g/L of total
polyphenols, whereas a typical bottle of white wine contains
200 to 300 mg/L total polyphenols. The second major
determinant of wine polyphenol content is the winemakers
themselves, who control the processing of the grapes to
achieve a specific flavor.
The proliferation of vascular SMCs is a key step in the
development of atherosclerosis.2,3 It follows that a sub-
Fig 1. Twelve-hour 3H-thymidine DNA synthesis assay for red
wine. x axis represents bovine aortic SMC samples treated with
different concentrations of dealcoholized red wine, shown as vol-
ume percentage. Negative control is 10% fetal bovine serum
growth media. y axis represents 3H-thymidine incorporation mea-
sured as counts per minute (cpm). A, Results for typical experi-
ment. B, Graph shows mean results for three experiments, normal-
ized as percentage of control. *P  .05 compared with negative
control.
Fig 2. Twelve-hour 3H-thymidine DNA synthesis assay for red
wine polyphenol extract. x axis represents bovine aortic SMC
samples treated with different concentrations of red wine polyphe-
nol extract, shown as volume percentage. Negative control is 10%
fetal bovine serum growth media. y axis represents 3H-thymidine
incorporation measured as counts per minute (cpm). A, Results for
typical experiment. B, Graph shows mean results for three experi-
ments, normalized as percentage of control. *P  .05 compared
with negative control.
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stance that inhibits the proliferation of SMCs may have a
potential beneficial effect on the development of atheroscle-
rotic disease. The goal of our study was to determine whether
red wine, red wine polyphenol extract, and resveratrol inhibit
SMC proliferation. Our results showed that resveratrol, red
wine, and red wine polyphenol extract all inhibit SMC prolif-
eration, as determined with 3H-thymidine DNA synthesis
assay. Our findings suggest that the beneficial health effects
of red wine consumption may be the result, in part, of the
inhibition of vascular SMC proliferation by red wine poly-
phenols.
Resveratrol is a nonflavonoid polyphenol found only in
the grape skin, so it is present much more in red wine than
in white. A typical resveratrol level in a bottle of red wine is
approximately 7 mg/L, and white wine contains only 0.5
mg/L resveratrol.6,7 The trans isomer of resveratrol is the
biologically active form, and cis resveratrol is absent in
grapes.8 The trans-cis isomerization of resveratrol in wine is
caused by natural light exposure.9
One recent study used a rabbit endothelial denudation
model to investigate the effects of resveratrol consumption
on vascular disease.10 These investigators were able to show
that rabbits fed a high resveratrol diet (4 mg/kg/d) had
less intimal hyperplasia develop than did controls. Further-
more, they were also able to show that the number of SMCs
in the thickened intima was significantly reduced in rabbits
that were fed a high resveratrol diet. These results correlate
with our findings with an in vitro model and suggest a
potential antiatherosclerotic benefit of resveratrol.
In consideration of the potential implications of our
data, some important points need to be made. Foremost
among them is that our study investigates the in vitro effect
of red wine and resveratrol applied directly to vascular
SMCs. This methodology, although similar to that used by
other investigations of the biologic effects of red wine
polyphenols, does not address the potential effects of he-
patic metabolism of resveratrol. In the liver, resveratrol is
predominantly metabolized to its diglucuronide conjugate
before it enters the systemic circulation. Whether resvera-
trol glucuronidation reduces its bioavailability is not fully
known. In a recent study, the presence of other polyphe-
nols commonly found in red wine was shown to decrease
resveratrol glucuronidation.11 This is believed to increase
the bioavailability of free resveratrol. In this manner, the
total amount of polyphenols in a bottle of red wine may be
as important to its potential health effects as is the resvera-
trol content. In our investigations, the concentration of
resveratrol we used was correlated with the amount of total
polyphenols in the dealcoholized red wine solution. For
example, the 0.1% wine solution contained approximately
the same amount of total polyphenols as the 10-m res-
veratrol solution. Diglucuronide conjugates of red wine
polyphenols are, unfortunately, not available to be isolated
with significant purity for study in cell culture.
Any observed antiproliferative effect in a regular red
wine drinker would likely be attributable to long-term
exposure (years) to these substances. Also, the pattern of
exposure is different, one of repeated brief exposures to the
circulating polyphenols rather than a single sustained expo-
sure lasting several hours. Our in vitro study used a short
time course. Nonetheless, it provides important observa-
tions with regard to the effects of red wine and red wine
polyphenols on vascular physiology.
Furthermore, in animal studies with resveratrol, de-
creased intimal hyperplasia was observed in rabbits fed a
high resveratrol diet (4 mg/kg/d) for 5 weeks.10 For the
75-kg man, that would be the equivalent of 300 mg/d
resveratrol. Given that the average concentration of res-
veratrol in red wine is 7 mg/L and a single glass contains
approximately 1 mg resveratrol, the doses used in the
animal studies are extremely high. Although long-term
exposure to low-dose resveratrol is postulated to produce a
beneficial antiatherosclerotic effect, these studies have not
been conducted.
Previous in vitro studies involving resveratrol have in-
vestigated its potential for use as an anticancer agent.
Multiple studies have shown resveratrol to have an antipro-
liferative effect on several different cancer cell lines, includ-
ing human breast cancer, oral squamous cell carcinoma,
Fig 3. Twelve-hour 3H-thymidine DNA synthesis assay for res-
veratrol. x axis represents bovine aortic SMC samples treated with
different concentrations of resveratrol, in micromolar. Negative
control is 10% fetal bovine serum growth media. y axis represents
3H-thymidine incorporation measured as counts per minute
(cpm). A, Results for typical experiment. B, Graph shows mean
results for three experiments, normalized as percentage of control.
*P  .05 compared with negative control.
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and different human leukemias.12-14 The inhibitory effect
of resveratrol in the previous cell culture studies was ob-
served at concentrations similar to those used in our inves-
tigations. Furthermore, a recently published study looking
solely at resveratrol showed an inhibitory effect on vascular
SMC proliferation.15 In our study, dealcoholized red wine
and red wine polyphenol extract were shown to have a
similar effect. Red wine contains other polyphenols in
addition to resveratrol, and our findings suggest that they
may also have an antiproliferative effect.
More recent studies involving resveratrol have sought
to understand the basis of its antiproliferative effects. A
number of reports suggest that resveratrol arrests cell cycle
progression at the S (DNA synthesis) phase of mitosis.16,17
These findings have been correlated with other studies that
have shown that resveratrol, in the presence of copper ions,
is capable of causing DNA strand breakage.18 Resveratrol
bound to cellular DNA has been postulated to form a
complex with Cu(II), reducing it to Cu(I). This causes
redox cycling of copper, which leads to the generation of
various reactive oxygen species, which serve as DNA cleav-
ing agents.19 On the basis of the previous mechanism, wine
drinkers may theoretically more fully enjoy the beneficial
effects of resveratrol than those who get their resveratrol
from other food sources because red wine is an excellent
source of dietary copper. Preliminary evidence in our labo-
ratory with cell cycle analysis indicates that a similar arrest in
S/G2 phase transition may also occur in SMCs exposed to
resveratrol. In addition to the cell cycle arrest mechanism,
researchers have proposed that resveratrol may inhibit cell
proliferation by causing apoptosis. Recent investigations
have shown that resveratrol exposure causes increased
apoptotic cell death and a decreased expression of the anti-
apoptotic protein Bcl-2 in human leukemia cells.20 Dimin-
ished expression of Bcl-2 has been observed in certain cell lines
undergoing apoptosis. Thus, resveratrol appears to inhibit cell
proliferation by more than one pathway.
Although our research has focused on smooth muscle
proliferation, red wine polyphenols are postulated to limit
the development of atherosclerosis by other mechanisms as
well. One study published in Nature (during the review of
this manuscript) has shown that endothelin-1 synthesis
with cultured bovine aortic endothelial cells could be in-
hibited by red wine polyphenol extract. With comparison of
polyphenol extracts from several different red wines, white
wine, and grape juice, inhibition of endothelin-1 synthesis
was directly related to the polyphenol content of the tested
wines. Furthermore, an MTT assay was performed, and as
in our study, no cytotoxic effect was observed in cell
samples exposed to red wine polyphenols.21
Another potential atheroprotective effect of red wine
polyphenols is by inhibition of LDL oxidation. With an in
vitro model, investigators were able to show that macro-
phages treated with red wine showed a significant inhibi-
tion of LDL oxidation.22 Evidence also shows that dealco-
holized red wine and red wine polyphenols inhibit platelet
aggregation and thromboxane synthesis.23,24 These find-
ings suggest that red wine may have multiple beneficial
Fig 4. Gross morphologic examination of SMCs treated with dealcoholized red wine, red wine polyphenol extract, or
resveratrol for 48 hours. Examination with low-power magnification (4) shows no gross morphologic changes in
treated SMC samples. However, dose-dependent decrease in cell number at higher concentrations is seen.
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effects in limiting the development of atherosclerotic dis-
ease.
In summary, ours is the first study to document that red
wine, red wine polyphenol extract, and resveratrol have a
dose-dependent inhibitory effect on the proliferation of
vascular SMCs in culture. Because SMC proliferation is an
important step in the development of atherosclerotic dis-
ease, our results suggest that the beneficial health effects of
red wine may be the result, in part, of the inhibition of
vascular SMC proliferation by its component polyphenols.
The focus of future studies should be to further elucidate
the atheroprotective properties of red wine polyphenols
and to compare the effects of individual polyphenols on
different cellular functions.
We thank Mauri Janik for her technical assistance in
preparation of the wine and polyphenol extracts.
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DISCUSSION
Unidentified speaker A. This is a really interesting paper.
However, your doses that you used for your polyphenols do not
look physiologic as compared with the doses that you used in the
concentrations for the wine. You used 0.1% for the wine concen-
trations, and for the polyphenols, it looks like you should have used
1 order of magnitude less. You should have had a result with 1
order of magnitude less, 0.001. The doses that you used were not
physiologic for the polyphenols.
Dr Omar Araim. Regarding the doses for the polyphenols,
the concentration of polyphenols in a bottle of wine is 2 g/L, so
that corresponds to a concentration at the 0.1% wine solution of 10
m for the polyphenols.
Unidentified speaker A. Are you going to be following
mechanistic data? Your preliminary data look quite interesting also.
This would suggest some problem with a molecular mediator that
would usually take the cells from S phase into G2. Which molecular
mediators are you focusing on?
Dr Araim. Our next step is to look at regulation of cell-cycle
proteins, and that is what we are planning on doing to confirm
these studies and to provide supportive data for this.
Unidentified speaker B. Have you considered this effect on
other cells? These experiments I think were confined to smooth
muscle cells. Does this effect require a single exposure to the
polyphenols, or do they continuously have to be present? This gets
to the implications of this under physiologic conditions because I
think, and correct me if I am wrong, to get a 1% level of wine
requires drinking about a bottle of wine an hour. If that has to be
sustained to inhibit coronary artery disease that could affect the
applicability of this.
Dr Araim. As far as the first question, there has been some
evidence in some leukemia cell lines and some lymphoid cell lines
that resveratrol has some sort of antiproliferative effect, and it has
been thought to be a potential anticancer agent in that regard.
As far as the second question, you are right. What we are
dealing with is 12-hour and 48-hour exposures, which even for the
excessive drinker would be a long time to be exposed to those
polyphenols. Those polyphenols are metabolized by the liver;
therefore, the physiologic doses that we talk about are not related
to the amount of time that a normal person would be exposed to
those polyphenols.
Dr Joseph Raffetto (Boston, Mass). I enjoyed your paper
very much. My question was, there are good epidemiologic data
that show that red wine, white wine, and beer are somewhat
effective in reducing overall cardiovascular risk effects. I was just
wondering if you looked at the ethanol component, if it also has
some of these effects on the smooth muscle proliferation, some of
the other findings.
Dr Araim. As far as what we did, we have not looked at the
specific effects of ethanol. The other effects of alcohol itself on
inhibiting atherosclerosis point to an antiplatelet effect and pros-
taglandin pathways effect, which we did not really explore because
what we were specifically looking at was just red wine and the basis
of our data was pretty much from that perspective. Our impetus for
doing this work was our first statement, namely that in France their
per capita red wine consumption is three times as much. Even in
other parts of Europe, where they drink the same amounts of
alcohol but not the same amounts of red wine, they do not have the
lesser cardiovascular mortality and morbidity that they do in
France.
Dr Colleen Brophy (Phoenix, Ariz). One final question. You
looked at one step in the process of intimal hyperplasia, namely,
proliferation, and I know your laboratory is capable of looking at
some of the more subsequent steps. In other words, the smooth
muscle cells need to migrate and produce matrix for the hyperplas-
tic response to progress. Have you examined these events?
Dr Araim. Not yet, but those are part of our future plans as
well, to explore those specific effects that you had mentioned. As
well, we were planning on looking at perhaps different types of
wine and wines with different polyphenol contents and comparing
them in that specific way.
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